Don't Blame Me, I'm the Scientist

Ned Shaw The public distrusts their science and even colleagues can question their motives, but researchers in controversial fields say they're making the world a better place. "I can't think of more important work that I could be doing [for public health]," says Jim Swauger, a toxicologist at R.J. Reynolds Tobacco Company. Tobacco companies? A great place to contribute to public health? It's no joke to Tony Albino, whose long track record in cancer research and stint as director of the Amer

Written byMignon Fogarty
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The public distrusts their science and even colleagues can question their motives, but researchers in controversial fields say they're making the world a better place. "I can't think of more important work that I could be doing [for public health]," says Jim Swauger, a toxicologist at R.J. Reynolds Tobacco Company.

Tobacco companies? A great place to contribute to public health?

It's no joke to Tony Albino, whose long track record in cancer research and stint as director of the American Health Foundation, make his current position particularly surprising. He is the public health director at Vector Tobacco.

Albino's move from an antismoking cancer center was a public relations coup for Vector. But he says it was a difficult decision for him. "The specific payoff here, of reducing the toxicity, morbidity, and mortality associated with tobacco, left me no choice," he says. "It was an opportunity I couldn't pass up."

RESEARCH ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies